Subscribe by Email

Onyx finishes FDA submission for blood cancer drug – BusinessWeek


 Onyx finishes FDA submission for blood cancer drug   BusinessWeek
Onyx finishes FDA submission for blood cancer drug
BusinessWeek
The South San Francisco, Calif., company has been submitting material to the FDA since January after the drug, called carfilzomib, received a "Fast Track" designation from the agency. That helps speed up the review of drugs that aim to treat serious or
Onyx files FDA application for quick drug reviewMarketWatch
Onyx Turns in FDA Application for Second Cancer DrugXconomy
Beacon BreakingNews – Onyx Submits Carfilzomib For FDA ApprovalThe Myeloma Beacon
RTT News -Pharmaceutical Business Review
all 27 news articles »
fda – Google News
Share and Enjoy:
  • services sprite Onyx finishes FDA submission for blood cancer drug   BusinessWeek
  • services sprite Onyx finishes FDA submission for blood cancer drug   BusinessWeek
  • services sprite Onyx finishes FDA submission for blood cancer drug   BusinessWeek
  • services sprite Onyx finishes FDA submission for blood cancer drug   BusinessWeek
  • services sprite Onyx finishes FDA submission for blood cancer drug   BusinessWeek
  • services sprite Onyx finishes FDA submission for blood cancer drug   BusinessWeek
  • services sprite Onyx finishes FDA submission for blood cancer drug   BusinessWeek
  • services sprite Onyx finishes FDA submission for blood cancer drug   BusinessWeek

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>